Microbot Medical targets $4M in 2026 revenue with the LIBERTY robotic system launch and a $1.9 price target after its capital raise. See why MBOT stock is a hold.
Microbot Medical Inc. (MBOT) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one ...
Microbot Medical Inc. (MBOT) has been beaten down lately with too much selling pressure. While the stock has lost 28.2% over the past four weeks, there is light at the end of the tunnel as it is now ...
Fintel reports that on November 28, 2025, HC Wainwright & Co. reiterated coverage of Microbot Medical (NasdaqCM:MBOT) with a Buy recommendation. As of November 17, 2025, the average one-year price ...
We recently published a list of the 10 Best Rising Penny Stocks to Buy According to Analysts. In this article, we are going to take a look at where Microbot Medical Inc. (NASDAQ:MBOT) stands against ...
Microbot Medical Inc. stock grades by Barron's. View MBOT fundamental and sentiment analysis powered by MarketGrader.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results